Data of those vaccine trials have not yet published. Phase 3 trials are considered by medical experts to be critical for any vaccine development and are needed to root out any potential side effects.
Those who sold are those who bought cheap last time and profit take.
If the vaccine trial result out with negative side effects, then glove stocks may continue to surge again.